parkinson-s-disease

Documents about parkinson-s-disease

• Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease#876455ClinicalTrials.gov
• A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease#805532ClinicalTrials.gov
• Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations#828036ClinicalTrials.gov
• Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease#828788ClinicalTrials.gov
• Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease#837335ClinicalTrials.gov
• PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy#843852ClinicalTrials.gov
• Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol#845366ClinicalTrials.gov
• Facial Expression Recognition and Mirror Neurons in Parkinson's Disease#853015ClinicalTrials.gov
• Botulinum A Toxin in Patients With Parkinson's Disease#863264ClinicalTrials.gov
• The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)#863495ClinicalTrials.gov
• Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease#855759ClinicalTrials.gov
• Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients#860863ClinicalTrials.gov
• Assessment of Methods Used in Evaluating Balance Rehabilitation in Parkinson's Patients#861536ClinicalTrials.gov
• From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease#676399Europe PMC
• 7.0T Magnetic Resonance Imaging Study of Parkinson's Disease#876293ClinicalTrials.gov
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.#6922OpenAlex
• Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies#871008ClinicalTrials.gov
• Support + High Intensity Functional Training for Parkinson's#804484ClinicalTrials.gov
• Altered central vestibular processing in Parkinson's disease with Pisa syndrome#273329Europe PMC
• The role of energy deficit in autophagy failure in Parkinson's disease#408588IBISS
• Prevalence of Parkinson’s Disease in 22q11.2 Deletion Syndrome: A Multicenter Study#477389Repositorio Universidad del Desarrollo
• Home-based Transcranial Static Magnetic Field Stimulation (tSMS) of the Supplementary Motor Area in Parkinson's Disease#813478ClinicalTrials.gov
• Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease#840577ClinicalTrials.gov
• Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease#841906ClinicalTrials.gov
• A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations#857119ClinicalTrials.gov
• Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease#878377ClinicalTrials.gov
• Ketamine for Veterans With Parkinson's Disease#878407ClinicalTrials.gov
• Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease#807831ClinicalTrials.gov
• Cognitive Effects of Exercise in Parkinson's Disease#813192ClinicalTrials.gov
• Effect of Exercise in Parkinsonism#848337ClinicalTrials.gov
• Comparative Study of Personality in Parkinson's Disease Patients With Other Chronic Pain#851398ClinicalTrials.gov
• Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease#857281ClinicalTrials.gov
• Study of the Effects of STN-DBS on Gait in Parkinson's Disease.#857476ClinicalTrials.gov
• Subthalamic Steering for Therapy Optimization in Parkinson's Disease#858339ClinicalTrials.gov
• A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)#862942ClinicalTrials.gov
• Comparison of Balance, Activity-specific Balance Confidence and Quality of Life in Parkinson's Patients#827783ClinicalTrials.gov
• Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects#874759ClinicalTrials.gov
• A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease#830387ClinicalTrials.gov
• Systemic Synuclein Sampling Study (S4)#843230ClinicalTrials.gov
• Plasma expression levels of microRNA-101 are downregulated in patients with Parkinson’s disease#393117OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Meta-analysis and pharmacoeconomic study of rasagiline versus selegiline in the treatment of Parkinson's disease#676303Europe PMC
• Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease#830899ClinicalTrials.gov
• Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients#837699ClinicalTrials.gov
• A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease#846770ClinicalTrials.gov
• Phase IIb Study of Intranasal Glutathione in Parkinson's Disease#856425ClinicalTrials.gov
• Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients#868335ClinicalTrials.gov
• Transcriptional regulation of α-synuclein by TRIM17, TRIM41 and ZSCAN21 pathway in Parkinson’s disease#231574HAL (France)
• Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's Disease#356590ClinicalTrials.gov
• The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease#801451ClinicalTrials.gov
• Effect of SpiroGym App in Patients With Parkinson's Disease#801915ClinicalTrials.gov